NMC Regulation: New NMC guidelines will make it more difficult for doctors to prescribe generic medications, and there will be consequences

 NMC Regulation: New NMC guidelines will make it more difficult for doctors to prescribe generic medications, and there will be consequences

NMC Requirements Doctors have been urged by the National Medical Commission (NMC) to abstain from dispensing branded generic medications in its Regulation on Professional Conduct of Registered Medical Practitioners. Despite the fact that doctors are now compelled to prescribe generic medications, no sanctions were stated in the guidelines that MNCs established in 2002.

PTI, New Delhi. New regulations from the National Medical Commission will make it harder for physicians to practise. According to the new regulations, all physicians must write generic prescriptions; otherwise, they risk being penalised and potentially having their licence to practise suspended.

What did the prior regulation contain?

The National Medical Commission (NMC) has also urged physicians to abstain from providing branded generic medications in its "Regulations relating to Professional Conduct of Registered Medical Practitioners" document. Despite the fact that doctors are now compelled to prescribe generic medications, no sanctions were stated in the guidelines that MNCs established in 2002.

What about the new regulation has changed?

According to the NMC guidelines, which were announced on August 2, the majority of India's public healthcare spending is made up of out-of-pocket expenses for medications. According to reports, generic medications are 30 to 80% less expensive than name-brand medications. As a result, prescription generic medications can lower their cost.

Why is the focus on generic medications?

Explain that a branded generic medicine is one that is produced by pharmaceutical businesses and marketed under the brand names of several corporations after the patent has expired. These medications may cost more than the generic equivalent produced in bulk, yet being less expensive than the branded patent version.